Zybio Inc. is a high-tech enterprise specialized in R&D, manufacture, sales and technical services of in vitro diagnostic reagents and equipment. Since its establishment in 2008, Zybio has more than 3,300 employees worldwide, of which R&D and technical service personnel account for nearly half. The company’s main product covers biochemistry, molecular diagnosis, microbiology products and raw materials. Until now, our products have been sold to nearly 100 countries, covering five continents.
Press Releases
-
July is approaching! The summer heat is matched only by the excitement bubbling in the world of laboratory medicine as we gear up for ADLM 2024 (formerly AACC). Zybio sincerely invite you to visit our booth 4617 during July 30 - August 1, 2024 to experience the reliability of a whole set of core lab solution and precision diagnostic solution.
We are about to exhibit Zybio core lab solution designed to advance laboratory medicine and improve patient care with Hematology, Coagulation, Urinalysis, Chemistry, CLIA and POCT equipment. Zybio precision diagnostic solution with molecular extraction and amplification expert system and MALDI-TOF equipment together with automated culture system make diagnosis more accurate and make life healthier.
Join us as we delve into the highlights and key attractions of this year's ADLM, setting the stage for a transformative journey in diagnostics and laboratory medicine!
Additional Info
Included in the Export Interest Directory?
YesBusiness Needs?
Distributor/Agent/RepresentativeProduct to be exported:
Chemistry, CLIA, POCT, Coagulation, Hematology, Urine, Microbiology, Molecular, Pathology.